MRK Jun 2025 180.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:38AM EDT. Market open.
| Previous close | 0.7400 |
| Open | 1.2300 |
| Bid | 0.5800 |
| Ask | 1.7100 |
| Strike | 180.00 |
| Expiry date | 2025-06-20 |
| Day's range | 1.2300 - 1.2300 |
| Contract range | N/A |
| Volume | |
| Open interest | 10 |
Business WireCDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults
RAHWAY, N.J., June 28, 2024--CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults
Investor's Business DailyDow Jones Powerhouse Merck Dives On Surprise FDA Rejection
Merck stock tumbled under its 50-day moving average Thursday after the FDA rejected its Daiichi Sankyo-partnered cancer drug.
Simply Wall St.Merck & Co., Inc.'s (NYSE:MRK) Stock Financial Prospects Look Bleak: Should Shareholders Be Prepared For A Share Price Correction?
Merck's (NYSE:MRK) stock is up by 2.7% over the past week. Given that the markets usually pay for the long-term...
© 2024 Yahoo. All rights reserved.